Organization and Summary of Significant Accounting Policies - Merger (Details) - Zymeworks Inc. - Theravance Biopharma, Inc. |
Jun. 28, 2026 |
|---|---|
| Business Combination, Description | |
| Business combination, date of acquisition agreement | Jun. 28, 2026 |
| Business combination, name of acquiree | Theravance Biopharma, Inc. |
| X | ||||||||||
- Definition Date when acquisition agreement is executed in business combination, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Name of acquiree in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|